By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – OpGen has raised $2.1 million, the Gaithersburg, Md., firm confirmed today.

The raise, which OpGen disclosed in a document filed with the US Securities and Exchange Commission on Friday, is bridge financing and will be used to support the commercialization of its flagship technology, the Argus Optical Mapping System, a company spokesman told GenomeWeb Daily News today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.